thymine has been researched along with Peritoneal Carcinomatosis in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pseudomyxoma peritonei is a rare disease with a reported prevalence of about 1-3 per million people annually." | 5.62 | A case of pseudomyxoma peritonei successfully treated with trifluridine/tipiracil (TAS-102) and bevacizumab after palliative debulking surgery. ( Gohda, Y; Hayama, N; Hirano, S; Igari, T; Miyazaki, H; Shimizu, S; Yano, H, 2021) |
| "Pseudomyxoma peritonei is a rare disease with a reported prevalence of about 1-3 per million people annually." | 1.62 | A case of pseudomyxoma peritonei successfully treated with trifluridine/tipiracil (TAS-102) and bevacizumab after palliative debulking surgery. ( Gohda, Y; Hayama, N; Hirano, S; Igari, T; Miyazaki, H; Shimizu, S; Yano, H, 2021) |
| " The favorable safety profile of trifluridine/tipiracil renders it a suitable option to be combined with other local therapies for metastatic lesions." | 1.56 | Trifluridine/tipiracil in combination with local therapy may be a favorable option for refractory metastatic colorectal cancer patients: A case report. ( Lin, BR; Lin, YL; Liu, KL, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, YL | 1 |
| Liu, KL | 1 |
| Lin, BR | 1 |
| Hirano, S | 1 |
| Gohda, Y | 1 |
| Miyazaki, H | 1 |
| Hayama, N | 1 |
| Shimizu, S | 1 |
| Igari, T | 1 |
| Yano, H | 1 |
| Opolon, P | 1 |
3 other studies available for thymine and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Trifluridine/tipiracil in combination with local therapy may be a favorable option for refractory metastatic colorectal cancer patients: A case report.
Topics: Adenocarcinoma; Aged; Drug Combinations; Humans; Liver Neoplasms; Male; Neoplasm Staging; Peritoneal | 2020 |
A case of pseudomyxoma peritonei successfully treated with trifluridine/tipiracil (TAS-102) and bevacizumab after palliative debulking surgery.
Topics: Bevacizumab; Cytoreduction Surgical Procedures; Drug Combinations; Humans; Male; Middle Aged; Perito | 2021 |
[Action of Thymobiol on the pH of the gastric fluid in patients undergoing digestive resuscitation].
Topics: Adult; Aged; Aluminum Hydroxide; Drug Combinations; Drug Evaluation; Female; Gastric Juice; Gastroin | 1975 |